RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUFFINI E
Collezione AOU San Luigi di Orbassano

Items : 6

Active thymus in adult with lung cancer: preliminary results from the Adult Thymic Project. in Updates in surgery / Updates Surg. 2024 Aug 21. doi: 10.1007/s13304-024-01953-w.

2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Ruffini E; Righi L; Rena O; Bonfanti P; Ambrogio C; Vaisitti F; Milazzo R; Ragazzini R; Patrucco E; Napoli F; Leo F; Sobrero S;

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2022 Dec 1;12(12):3009. doi: 10.3390/diagnostics12123009.

2022
AOU San Luigi di Orbassano
AOU Novara

Ruffini E; Cacciatore CC; La Paglia D; Scopis F; Rudella S; Mellone F; Ganio S; Vaisitti F; Rapanà R; Cartia CF; Ceraolo S; Sobrero S; Moro J; Leo F;

Risk of recurrence in stage I adenocarcinoma of the lung: a multi-institutional study on synergism between type of surgery and type of nodal staging. in Journal of thoracic disease / J Thorac Dis. 2019 Feb;11(2):564-572. doi: 10.21037/jtd.2019.01.31.

2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Casadio C; Oliaro A; Filosso PL; Paci M; Marchese V; Ventura L; Lausi PO; Errico L; Vannucci J; Ampollini L; Rena O; Evangelista A; Guerrera F; Lococo F; Puma F; Ruffini E; Ardissone F;

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.

2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Riganti C; Scagliotti GV; Papotti M; Di Maio M; Novello S; Righi L; Ruffini E; Bussolino F; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Ananthanarayanan P; Bironzo P; Gagliasso M; Milosevic V; Costardi L; Maletta F; Salaroglio IC; Kopecka J; Napoli F; Pradotto M;

CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. in Oncotarget / Oncotarget. 2014 Aug 15;5(15):6191-205. doi: 10.18632/oncotarget.2186.

2014
AOU San Luigi di Orbassano

Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A;

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Mar 20;28(9):1534-9. doi: 10.1200/JCO.2009.25.9275. Epub 2010 Feb 22.

2010
AOU San Luigi di Orbassano

Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G;